| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. | Director | Common Stock | 34,389 | $147 K | $4.27 | Jun 13, 2024 | Direct |
| Day One Biopharmaceuticals, Inc. | Director | Director Stock Option (Right to buy Common Stock) | 37,500 | Jun 22, 2023 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Stock Option (right to buy Common Stock) | 32,335 | May 23, 2024 | Direct | ||
| G1 Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 30,000 | Jun 13, 2024 | Direct | ||
| TScan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 23,750 | Jun 12, 2024 | Direct | ||
| NextCure, Inc. | Director | Stock Option (Right to Buy) | 14,250 | Jun 22, 2023 | Direct | ||
| Turning Point Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Aug 17, 2022 | Direct |